4.5 quarters of funding remaining and we expect FDA approval in 2025 before our reserves dip below 2 quarters.
We probably won't need to do another CR but, even if we do, it would be after FDA approval and at a much higher SP, well north of $2.
Ann: Imricor Q4 CY24 Quarterly Activities Report and Appendix 4C, page-3
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.55 |
Change
-0.030(1.90%) |
Mkt cap ! $506.3M | |||
| Open | High | Low | Value | Volume |
| $1.58 | $1.58 | $1.54 | $105.5K | 68.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1101 | $1.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.58 | 2218 | 2 |
View Market Depth
| Last trade - 10.32am 17/06/2025 (20 minute delay) ? |
| IMR (ASX) Chart |